THE PREUSS FOUNDATION SEMINAR ON VACCINE THERAPY FOR MALIGNANT PRIMARY BRAIN TUMORS February 15-17, 199 8, La Jolla, Calif.
作者： John H. Sampson
关键词:
摘要:
oup.com
oxfordjournals.org
sci-hub.se 参考文章(86)
Herrlinger U, Breakefield Xo, Reznikoff G, Kramm Cm, Louis Dn, Finkelstein D, Yu Js, Dranoff G, Johnston Km, Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Cancer Gene Therapy. ,vol. 4, pp. 345- ,(1997)
Gjerset R, Dorigo O, Koziol J, Fakhrai H, Sobol Re, Shawler D, Royston I, Khaleghi T, Carson C, Shiftan Ta, Interleukin-2 gene therapy in a patient with glioblastoma. Gene Therapy. ,vol. 2, pp. 164- 167 ,(1995)
C Linington, H Lassmann, S Weerth, T Berger, K Kojima, H Wekerle, Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Laboratory Investigation. ,vol. 76, pp. 355- 364 ,(1997)
Elliott L, Brooks W, Roszman T, Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas. Journal of the National Cancer Institute. ,vol. 78, pp. 919- 922 ,(1987)
M S Mahaley, R E Woosley, T L Roszman, W H Brooks, Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours. Clinical and Experimental Immunology. ,vol. 29, pp. 61- 66 ,(1977)
John H. Sampson, Darell D. Bigner, Glenn Dranoff, Cytokine-Based Gene Therapy for Brain Tumors Humana Press, Totowa, NJ. pp. 231- 294 ,(1998) , 10.1007/978-1-59259-478-8_13
Wallace W. Tourtellotte, C. W. M. Adams, J. F. Hallpike, Multiple Sclerosis: Pathology, Diagnosis, and Management ,(1983)
S Carrel, S Miescher, T L Whiteside, V von Fliedner, Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. Journal of Immunology. ,vol. 136, pp. 1899- 1907 ,(1986)
T L Roszman, L A Morford, L H Elliott, S L Carlson, W H Brooks, T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. Journal of Immunology. ,vol. 159, pp. 4415- 4425 ,(1997)
Gene therapy for neurological disorders and brain tumors Humana Press. ,(1997) , 10.1007/978-1-59259-478-8